Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...

SAN FRANCISCO -- In order to maximize weight loss, a GLP-1 receptor agonist may be needed both before and after bariatric ...

SAN FRANCISCO -- Menopause hormone therapy (MHT) was tied to a weight-loss boost in postmenopausal women taking a weight loss ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side effect of weight loss drugs.

California Trim Rx has been providing a local, community-based experience for residents in Encinitas and the surrounding ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.